Huaxia Eye Hospital Group Co.,Ltd.

301267

CNE100005WL5

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. Other stock markets 18:00:00 2024-07-14 EDT			5-day change	1st Jan Change
19.96 ^CNY	-2.40%		+1.84%	-37.80%

07-09	Huaxia Eye Hospital Group Co.,Ltd. Announces Final Cash Dividend of A Shares for 2023, Payable on 15 July 2024	CI
07-01	Tranche Update on Huaxia Eye Hospital Group Co.,Ltd.'s Equity Buyback Plan announced on January 9, 2024.	CI

Huaxia Eye Hospital Group Co.,Ltd. Announces Final Cash Dividend of A Shares for 2023, Payable on 15 July 2024

July 09, 2024 at 03:32 pm

Huaxia Eye Hospital Group Co.,Ltd. announced final cash dividend of CNY 1.10000000 per 10 A shares (tax included) for 2023. Record date: 12 July 2024. Ex-date: 15 July 2024.

Payment date: 15 July 2024.

Latest news about Huaxia Eye Hospital Group Co.,Ltd.

Huaxia Eye Hospital Group Co.,Ltd. Announces Final Cash Dividend of A Shares for 2023, Payable on 15 July 2024	07-09	CI
Tranche Update on Huaxia Eye Hospital Group Co.,Ltd.'s Equity Buyback Plan announced on January 9, 2024.	07-01	CI
Huaxia Eye Hospital Group Co.,Ltd. agreed to acquire Xiamen Huaxia Juxin No. 1 Investment Consulting Co., Ltd. from Xiamen Huaxia Juxin No. 1 Investment Partnership Enterprise (Limited Partnership) and Nanjing Xinke Dongzheng 01 Venture Capital Partnership Enterprise (Limited Partnership) for approximately CNY 500 million.	04-29	CI
Huaxia Eye Hospital Group Co.,Ltd. Proposes Final Cash Dividend for 2023	04-26	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-25	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25	CI
Tranche Update on Huaxia Eye Hospital Group Co.,Ltd.'s Equity Buyback Plan announced on January 9, 2024.	04-01	CI
Huaxia Eye Hospital Group Co.,Ltd. announces an Equity Buyback for CNY 250 million worth of its shares.	01-08	CI
Huaxia Eye Hospital Group Co.,Ltd. authorizes a Buyback Plan.	01-07	CI
Huaxia Eye Hospital Group Co.,Ltd.(SZSE:301267) added to Shenzhen Stock Exchange Component Index	12-12	CI
Huaxia Eye Hospital Group Co.,Ltd.(SZSE:301267) added to Shenzhen Stock Exchange Component A Share Index	12-12	CI
Huaxia Eye Hospital Chairman, Actual Controller Detained for Personal Reasons	12-07	MT
Certain A Shares of Huaxia Eye Hospital Group Co.,Ltd. are subject to a Lock-Up Agreement Ending on 7-NOV-2023.	11-06	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Huaxia Eye Hospital Group Co.,Ltd.(XSEC:301267) added to S&P Global BMI Index	23-09-18	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Huaxia Eye Hospital Group Co.,Ltd. agreed to acquire an additional 33% stake in Hefei Shining Eye Hospital Co., Ltd from Anhui Zhongshi Ophthalmologists Group Management Partnership Enterprise (Limited Partnership), Hefei Aiweixi Eyewear Co., Ltd., Anhui Shining Hospital Management Co., Ltd. and Chen Linyi for CNY 70 million	23-08-20	CI
Huaxia Eye Hospital Group Co.,Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on July 11, 2023	23-07-04	CI
Huaxia Eye Hospital Group Co.,Ltd.(XSEC:301267) added to FTSE All-World Index	23-06-19	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-23	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-11-03	CI
Huaxia Eye Hospital Group Co.,Ltd. has completed an IPO in the amount of CNY 3.0528 billion.	22-10-25	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-10-13	CI
Huaxia Eye Hospital Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-10-13	CI

Chart Huaxia Eye Hospital Group Co.,Ltd.

Duration

Period

Chart Huaxia Eye Hospital Group Co.,Ltd.

More charts

Huaxia Eye Hospital Group Co Ltd is a China-based company mainly engaged in ophthalmic medical business. The Company's main business is to provide diagnosis and treatment services for ophthalmic diseases through ophthalmic medical institutions, including specialized medical services for cataract, refraction, fundus diseases, strabismus, amblyopia and pediatric ophthalmology, ocular surface diseases, glaucoma and others. The Company is also engaged in glasses and pharmacy retail business. The Company mainly conducts its business in the domestic market.

Sector

Healthcare Facilities & Services

Calendar

2024-08-28 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Huaxia Eye Hospital Group Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

19.96 CNY

Average target price

39.52 CNY

Spread / Average Target

+98.00%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Doctor's Office

	1st Jan change	Capi.
HUAXIA EYE HOSPITAL GROUP CO.,LTD.	-37.80%	2.35B
TOPCHOICE MEDICAL CO., INC.	-26.68%	2.52B
AIRSCULPT TECHNOLOGIES, INC.	-37.78%	265M
EUROEYES INTERNATIONAL EYE CLINIC LIMITED	+1.73%	226M
AESTHETIC CONNECT	-32.40%	122M
MEDSCI HEALTHCARE HOLDINGS LIMITED	-63.94%	119M

Doctor's Office